Page 58 - TD-1-1

Tumor Discovery Dual-targeting of cancer receptors by nanoparticles

using acacia luciana flower extract in MCF-7 breast cancer factor, Mcl-1, correlates with sensitivity to combined Bcl-2/
cells: Activation of bak1 and bclx for cancer therapy. Bcl-xL blockade. Mol Cancer Res, 15: 259–268.
BioNanoScience, 10: 683–689.
36. Williams MM, Lee L, Werfel T, et al., 2018, Intrinsic
27. Sargazi A, Majd MH, 2017, Different applications of magnetic apoptotic pathway activation increases response to anti-
nanoparticles in the rapid monitoring of ochratoxin A. estrogens in luminal breast cancers. Cell Death Dis, 9: 21.
Orient J Chem, 33: 346–354.
37. Oltersdorf T, Elmore SW, Shoemaker AR, et al., 2005, An
28. Saei AA, Barzegari A, Majd MH, et al., 2014, Fe O 4 inhibitor of Bcl-2 family proteins induces regression of solid
3
nanoparticles engineered for plasmid DNA delivery to tumours. Nature, 435(7042): 677–681.
Escherichia coli. J Nanopart Res, 16: 2521.
38. Ali S, Rasool M, Chaoudhry H, et al., 2016, Molecular
29. Almalik A, Benabdelkamel H, Masood A, et al., 2017, mechanisms and mode of tamoxifen resistance in breast
Hyaluronic acid coated chitosan nanoparticles reduced the cancer. Bioinformation, 12(3): 135.
immunogenicity of the formed protein corona. Sci Rep, 7: 39. Xavier MA, de Oliveira MT, Baranoski A, et al., 2018, Effects
10542.
of folic acid on the antiproliferative efficiency of doxorubicin,
30. Patra JK, Das G, Fraceto LF, et al., 2018, Nano based drug camptothecin and methyl methanesulfonate in MCF-7 cells
delivery systems: Recent developments and future prospects. by mRNA endpoints. Saudi J Biol Sci, 25: 1568–1576.
J Nanobiotechnol, 16: 1–33.
40. Cao DZ, Sun WH, Ou XL, et al., 2005, Effects of folic acid
31. Behdarvand N, Torbati MB, Shaabanzadeh MJ, 2020, on epithelial apoptosis and expression of Bcl-2 and p53 in
Tamoxifen-loaded PLA/DPPE-PEG lipid-polymeric premalignant gastric lesions. World J Gastroenterol, 11(11):
nanocapsules for inhibiting the growth of estrogen-positive 1571.
human breast cancer cells through cell cycle arrest. J 41. He C, Heidari Majd M, Shiri F, et al., 2021, Palladium and
Nanopart Res, 22: 1–15.
platinum complexes of folic acid as new drug delivery
32. Šmejkalová D, Hermannová M, Šuláková R, et al., 2012, systems for treatment of breast cancer cells. J Mol Struct,
Structural and conformational differences of acylated 1229: 129806.
hyaluronan modified in protic and aprotic solvent system. 42. Popgeorgiev N, Sa JD, Jabbour L, et al., 2020, Ancient
Carbohydr Polym, 87: 1460–1466.
and conserved functional interplay between Bcl-2 family
33. Marshalek JP, Sheeran PS, Ingram P, et al., 2016, Intracellular proteins in the mitochondrial pathway of apoptosis. Sci Adv,
delivery and ultrasonic activation of folate receptor-targeted 6: eabc4149.
phase-change contrast agents in breast cancer cells in vitro. J 43. Siddiqui WA, Ahad A, Ahsan HJ, 2015, The mystery of
Control Release, 243: 69–77.
BCL2 family: Bcl-2 proteins and apoptosis: An update. Arch
34. Yang C, He Y, Zhang H, et al., 2015, Selective killing of breast Toxicol, 89: 289–317.
cancer cells expressing activated CD44 using CD44 ligand- 44. Salakou S, Kardamakis D, Tsamandas AC, et al., 2007,
coated nanoparticles in vitro and in vivo. Oncotarget, 6: Increased Bax/Bcl-2 ratio up-regulates caspase-3 and
15283–15296.
increases apoptosis in the thymus of patients with
35. Williams MM, Lee L, Hicks DJ, et al., 2017, Key survival myasthenia gravis. In Vivo (Athens, Greece), 21: 123–132.

Volume 1 Issue 1 (2022) 9 https://doi.org/10.36922/td.v1i1.41